Scinai Immunotherapeutics Ltd.
SCNI | NASDAQ
$1.91
+$0.22 (+13.02%)
At close: Sep 22, 2026, 4:00 PM ET
$1.73
-$0.18 (-9.42%)
After-hours:
Sep 22, 2026, 7:59 PM ET
Market Data
Market Cap $873.63K
Enterprise Value $1.6M
Beta 2.08
Average Volume 188.97K
Shares Outstanding (Diluted) 57M
Shares Change YoY 35723.87%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US09073Q4029
Price Performance
Price Change 1M -47.8%
Price Change 3M 490.9%
Price Change 6M 152.2%
Price Change YTD 131.7%
Price Change 1Y 16.6%
Price Change 3Y -81.5%
Price Change 5Y -99.3%
1M CAGR (ann.) -31.0%
1Y CAGR (ann.) -89.2%
5Y CAGR (ann.) -76.5%
All-Time CAGR -50.5%
Valuation
PE Ratio -0.00
Forward PE N/A
PEG Ratio 0.00
Forward PEG 0.00
PS Ratio 0.58
Forward PS N/A
PB Ratio 0.07
P/FCF Ratio -0.12
P/Adj. FCF Ratio -0.12
P/OCF Ratio -13.00
EV/Sales 1.07
EV/EBIT -0.19
EV/EBITDA -0.24
EV/FCF -0.21
Earnings Yield -3678106.5%
FCF Yield -862.0%
Adj. FCF Yield -865.9%
Financial Health
Net Cash $2.2M
Total Debt $3.58M
Cash & Short-Term Investments $2.85M
Total Assets $17.17M
Current Ratio 1.56
Quick Ratio 1.56
Debt / Equity Ratio 0.31
Debt / EBITDA -0.54
Debt / FCF -0.48
OCF / Debt -2.07
Interest Coverage -39.09
Altman Z-Score -11.48
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin -252.4%
Operating Profit Margin -563.9%
EBITDA Margin -445.7%
Net Profit Margin -177.0%
FCF Margin -504.2%
Adj. FCF Margin -506.5%
SBC / Revenue 2.3%
SBC Impact (per share) -0.4%
Returns
Return on Assets -15.4%
Return on Equity -26.6%
Return on Invested Capital -55.0%
Return on Capital Employed -56.4%
Return on Tangible Assets -15.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 58.1%
Revenue CAGR 5Y 69.4%
Revenue CAGR 10Y 47.1%
EPS CAGR 3Y 74.0%
EPS CAGR 5Y 78.8%
EPS CAGR 10Y 30.5%
FCF CAGR 3Y -4.5%
FCF CAGR 5Y 8.3%
FCF CAGR 10Y 8.2%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Dec 1, 2026
EPS Estimate (next Q) -$8.50
EPS Growth Est (next Q) -76.2%
Revenue Est (next Q) $494.55K
Revenue Growth Est (next Q) 78.3%
Cash Flow
Operating Cash Flow $-7.4M
Free Cash Flow $-7.53M
Adj. Free Cash Flow $-7.57M
FCF Per Share -$0.13
OCF Per Share -$0.13
OCF/S Ratio -495.7%
Income Statement
Revenue $1.49M
Gross Profit $-3.77M
Operating Income $-8.42M
EBITDA $-6.66M
Net Income $-2.64M
EPS (Diluted) -$62,160
Revenue / Employee $33.19K
Profit / Employee $-58.74K
Employees 45
Add to Watchlist
Select watchlists to add or remove SCNI